Ziping Wei

Company: Bliss Biopharma

Job title: Chief Executive Officer

Seminars:

Development of Eribulin-based Antibody-Drug Conjugates 4:30 pm

Introduction of Eribulin-based ADC BB-1701 and BB-1705 Discussion of preclinical results of Eribulin-based ADCs Progress of BB-1701 phase 1/2 clinical developmentRead more

day: Day One